Mariner
PRCT icon

Mariner’s Procept Biorobotics PRCT Stock Holding History

Mariner’s Portfolio PRCT Stock Details PRCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.09M Buy
48,190
+27,775
+136% +$695K ﹤0.01% 1881
2026
Q1 		$511K Buy
20,415
+1,692
+9% +$47.7K ﹤0.01% 2476
2025
Q4 		$589K Buy
18,723
+2,177
+13% +$72.2K ﹤0.01% 2339
2025
Q3 		$591K Buy
16,546
+1,251
+8% +$57.1K ﹤0.01% 2297
2025
Q2 		$881K Buy
15,295
+2,539
+20% +$144K ﹤0.01% 1891
2025
Q1 		$743K Buy
12,756
+4,350
+52% +$297K ﹤0.01% 1891
2024
Q4 		$677K Buy
8,406
+2,429
+41% +$208K ﹤0.01% 1938
2024
Q3 		$479K Buy
+5,977
New +$425K ﹤0.01% 2156

Other funds holding PRCT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $99.8B AUM 45.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
CC
Chicago Capital Chicago, Illinois $4.15B AUM 31.09% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Mariner's PRCT Position: Q2 2026 in Review

Mariner increased its Procept Biorobotics (PRCT) stake by 136% in Q2 2026, buying an estimated $695K and bringing the position to 48,190 shares worth $1.09M. The position accounts for ﹤0.01% of the portfolio, ranked #1881.

Mariner first reported a position in PRCT in Q3 2024 and has held it in 8 quarters since. 254 funds tracked by Wall St. Rank hold PRCT as of Q2 2026.

  • Mariner held 48,190 shares of Procept Biorobotics worth $1.09M as of Q2 2026.
  • Mariner bought 27,775 Procept Biorobotics shares in Q2 2026, an estimated $695K.
  • Procept Biorobotics made up ﹤0.01% of Mariner's portfolio in Q2 2026, its #1881 holding.
  • Mariner first reported a position in Procept Biorobotics in Q3 2024 and has held it in 8 quarters since.
  • 254 funds tracked by Wall St. Rank held Procept Biorobotics as of Q2 2026.

Based on Mariner's 13F filing for Q2 2026, filed 13 Aug 2026.